Is Mono Pharmacare overvalued or undervalued?

Sep 11 2025 08:06 AM IST
share
Share Via
As of September 10, 2025, Mono Pharmacare is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 13.44 and a year-to-date return of -32.18%, significantly underperforming compared to industry peers like Sun Pharma and Cipla.
As of 10 September 2025, the valuation grade for Mono Pharmacare has moved from fair to expensive. The company is currently considered overvalued based on its financial ratios. Key ratios include a PE ratio of 13.44, an EV to EBITDA of 10.83, and a ROE of 10.99%.

In comparison to its peers, Mono Pharmacare's valuation appears high, especially when contrasted with Sun Pharma's PE ratio of 33.38 and Cipla's PE ratio of 23.41, both of which indicate a premium valuation in the industry. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -32.18%, significantly lagging behind the Sensex's positive return of 5.62%.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is Mono Pharmacare falling/rising?
Dec 13 2025 01:24 AM IST
share
Share Via
How has been the historical performance of Mono Pharmacare?
Nov 28 2025 10:44 PM IST
share
Share Via
Why is Mono Pharmacare falling/rising?
Nov 20 2025 12:18 AM IST
share
Share Via
How has been the historical performance of Mono Pharmacare?
Nov 18 2025 11:03 PM IST
share
Share Via
Is Mono Pharmacare overvalued or undervalued?
Nov 11 2025 08:14 AM IST
share
Share Via
Is Mono Pharmacare overvalued or undervalued?
Nov 07 2025 08:14 AM IST
share
Share Via
Why is Mono Pharmacare falling/rising?
Oct 16 2025 12:03 AM IST
share
Share Via
Most Read
Galada Finance Ltd is Rated Sell
19 minutes ago
share
Share Via
Gujarat Cotex Ltd is Rated Sell
19 minutes ago
share
Share Via
Beryl Drugs Ltd is Rated Sell
19 minutes ago
share
Share Via
Nutech Global Ltd is Rated Hold
19 minutes ago
share
Share Via